MoneyWorks4Me

Raymed Labs - Quaterly Results

04 Nov 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2023, as compared to corresponding quarter of last year.The Net Loss for the quarter ended September 2023 is Rs. -0.17 millions as compared to Net Loss of Rs. -0.24 millions of corresponding quarter ended September 2022 Operating profit Margin for the quarter ended September 2023 improved to -0.16% as compared to -0.23% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00 0.00
PBIDT -0.16 -0.23 -30.43 -0.31 -0.73 -57.53 -1.65 -0.77 114.29
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.16 -0.23 -30.43 -0.31 -0.73 -57.53 -1.65 -0.77 114.29
Depreciation 0.01 0.01 0.00 0.02 0.02 0.00 0.06 0.05 20.00
PBT -0.17 -0.24 -29.17 -0.33 -0.75 -56.00 -1.71 -0.82 108.54
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.17 -0.24 -29.17 -0.33 -0.75 -56.00 -1.71 -0.82 108.54
Equity 42.74 42.74 0.00 42.74 42.74 0.00 42.74 42.74 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Uflex 663.05
EPL 238.55
AGI Greenpac 803.90
Huhtamaki India 242.40
TCPL Packaging 4107.35
View more..